Search

Your search keyword '"Holzer, Barbara"' showing total 367 results

Search Constraints

Start Over You searched for: Author "Holzer, Barbara" Remove constraint Author: "Holzer, Barbara"
367 results on '"Holzer, Barbara"'

Search Results

2. Bridging basic science and applied diagnostics: Comprehensive viral diagnostics enabled by graphene-based electronic biosensor technology advancements

3. Amyloid-like p53 as prognostic biomarker in serous ovarian cancer—a study of the OVCAD consortium

4. Comparative study between virus neutralisation testing and other serological methods detecting anti-SARS-CoV-2 antibodies in Europe, 2021

10. COVID-19 serology in nephrology healthcare workers

11. Prognostic significance of circulating tumor cells and tumor related transcripts in small cell lung cancer: A step further to clinical implementation.

14. Response to Immunization against SARS-CoV-2 and Risk of Omicron Infection in Dialysis Patients: A Prospective Cohort Study

15. The worse we feel, the more intensively we need to stick together: a qualitative study of couples’ emotional co-regulation of the challenge of multimorbidity

16. One-Year Follow-Up of COVID-19 Patients Indicates Substantial Assay-Dependent Differences in the Kinetics of SARS-CoV-2 Antibodies

17. Patienten-Entscheidungshilfen zur Werteklärung und Präferenzerhebung - Herausforderungen und Entwicklungen

28. Effect of short-term storage of blood samples on gene expression in lung cancer patients.

30. Spike Protein Antibodies Mediate the Apparent Correlation between SARS-CoV-2 Nucleocapsid Antibodies and Neutralization Test Results

32. Correction: Protective porcine influenza virus-specific monoclonal antibodies recognize similar haemagglutinin epitopes as humans

33. A comprehensive antigen production and characterisation study for easy-to-implement, specific and quantitative SARS-CoV-2 serotests

34. Clinical validation of the Siemens quantitative SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titers

35. Antibody Seroprevalence and Rate of Asymptomatic Infections With SARS-CoV-2 in Austrian Hospital Personnel

36. Protective porcine influenza virus-specific monoclonal antibodies recognize similar haemagglutinin epitopes as humans

37. Clinical validation of the quantitative Siemens SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titers

38. Antibody seroprevalence and rate of asymptomatic infections with SARS-CoV-2 in Austrian hospital personnel

39. A comprehensive antigen production and characterization study for easy-to-implement, highly specific and quantitative SARS-CoV-2 antibody assays

40. Can We Protect Those We Care for in A Pandemic? - Prevalence of Neutralizing Antibodies against SARS-CoV-2 in Nursing Homes

42. Establishment of a Pig Influenza Challenge Model for Evaluation of Monoclonal Antibody Delivery Platforms

43. Covid-19 serology in nephrology health care workers

44. Protective porcine influenza virus-specific monoclonal antibodies recognize similar haemagglutinin epitopes as humans

45. Couples Adjusting to Multimorbidity: A Dyadic Study on Disclosure and Adjustment Disorder Symptoms

47. Can We Protect Those We Care for in A Pandemic? - Prevalence of Neutralizing Antibodies against SARSCoV-2 in Nursing Homes.

48. Ganjam virus/Nairobi sheep disease virus induces a pro-inflammatory response in infected sheep

50. Zunehmende Multimorbidität im Krankheitsspektrum einer alternden

Catalog

Books, media, physical & digital resources